In line with these data, C/EBPδ indeed acts as a tumor suppressor in breast cancer [21,22,23], ovarian serous carcinoma [24], cervical carcinoma [25], leukemia [26] and hepatocellular carcinoma [27,28]. Here, CEBPD is linked to hepatocellular carcinoma.